Compounds are described of the formulae (1a) and (1b)
in which:
-COR' is an ester group,
n is 1 or 2,
W is C1-7 alkylene,
X is cis or trans -CH=CH or -CH2CH2-,
Y is a saturated heterocyclic amino group,
R2 is substituted or unsubstituted phenylalkyl, thienylal- kyl or naphthylalkyl or cinnamyl, and
R' is -H or C1-5 alkanoyl,
including their salts.
These compounds inhibit blood platelet aggregation and bronchoconstriction and may be formulated for use as antithrombotic or antiasthmatic agents.
描述了式 (1a) 和 (1b) 所示的化合物,其中:-COR' 是
酯基,n 是 1 或 2,W 是 C1-7 亚烷基,X 是顺式或反式 -CH=CH 或 -CH2CH2-,Y 是饱和杂环
氨基,R2 是取代或未取代的
苯基烷基、
噻吩烷基或
萘基烷基或肉桂基,R' 是 -H 或 C1-5 烷酰基,包括它们的盐。 这些化合物可抑制血小板聚集和支气管收缩,可配制成抗血栓或抗哮喘药物。